4EFTHIMIOU P, SCHWARTZMAN S, KAGEN L J. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients [ J ]. Ann Rheum Dis, 2006, 65 (9): 1233-1236.
4Bohan A,Peter JB. Polymyositis and dermatomyositis[J].N Engl J Med,1975,292(7):344.
5Dalakas MC. Muscle biopsy findings in inflammatory myopathies[J]. Rheum Dis Clin North Am, 2002, 28: 779 - 798.
6Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis [J].Lancet, 2003,362: 971 - 982.
7Dalakas MC. Understanding the immunopathogenesis of inclusion body myositis: present and future prospeets[J].Rev Neurol, 2002,158 : 948 - 958.
8Akira I,Satosi K, Yideng L. Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis [J].Muscle Nerve, 2000,23:385 - 392.
9Walker EJ,Jeffrey PD. Polymyositis and molecular mimicry, a mechanism of autoimmunity[J]. Lancet, 1986,13 : 605 - 607.
10ShamimEA, Rider LG, Pandey JP. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians ethnogeographie influences in the genetics and clinical expression of myositis[J].Arthritis Rheum ,2002,46:1 885 - 1 893.
